Cancer Genome Sequencing Market by Technology Types (Second and Third Generation Sequencing), and Cancer Types (Breast Cancer, Prostate Cancer, Colorectal Cancer) and Forecast 2017-2021

Cancer Genome Sequencing Market by Technology Types (Second and Third Generation Sequencing), and Cancer Types (Breast Cancer, Prostate Cancer, Colorectal Cancer) and Forecast 2017-2021

The continuing advancement of next-generation technology in terms of data capacity per instrument run and read length is likely to accelerate the rate of whole genome sequencing, at ever-decreasing costs. Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a group of tumor cells. The cancer genome engineering market is growing rapidly due to the technological advancements, government initiatives, R&D funding in the genome sequencing sector and higher incidence of cancer worldwide. The next-generation platforms can produce data to characterize gene expression, methylation, histone packaging, transcription factor and other regulatory protein binding positions, where it is quite possible to comprehensively characterize a broad spectrum of genomic alterations among sets of tumor samples.

The global cancer genome sequencing market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market in terms of technology types (second and third generation sequencing), cancer types (breast cancer, prostate cancer, colorectal cancer, etc.) and forecasts growth trends (CAGR% – 2017 to 2021).

The global cancer genome sequencing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cancer genome sequencing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global cancer genome sequencing market and included in this report are Pacific Biosciences of California, Inc., GE Healthcare, Beckman Genomics, Genewiz, Inc. Foundation Medicine, Inc. Myriad Genetics, Illumina, Inc. Thermo Fisher Scientific, Inc., and F. Hoffman la Roche AG.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue US$ Million, 2014-2021)
    • Forecast Estimation (Revenue US$ Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Cancer Genome Sequencing Market

1. Technology Type
1.1. Second Generation Sequencing
1.2. Third Generation Sequencing

2. Cancer Type
2.1. Breast Cancer
2.2. Prostate Cancer
2.3. Colorectal Cancer
2.4. Other Cancers

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. ACGT, Inc.
4.2. Ambry Genetics Corp.
4.3. Beckman Coulter Genomics, Inc.
4.4. BGI Americas Corporation
4.5. Cedars-Sinai Genomics Core
4.6. F. Hoffmann-La Roche Ltd.
4.7. GE Healthcare
4.8. Geisinger Health System
4.9. Genomic Health, Inc.
4.10. Illumina, Inc.
4.11. Lifecode Health
4.12. Mayo Clinic
4.13. Myriad Genetics, Inc.
4.14. Otogenetics Corporation
4.15. Pathway Genomics Corporation
4.16. Thermo Fisher Scientific, Inc.
4.17. Zymo Research Corporation

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*